Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1b, Age-Descending, Dose-Escalation Study to Evaluate Entervax (a bivalent vaccine against enteric fever) in an Endemic Region in South Asia

Next Previous
Search
Trial Profile

A Phase 1b, Age-Descending, Dose-Escalation Study to Evaluate Entervax (a bivalent vaccine against enteric fever) in an Endemic Region in South Asia

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 15 Oct 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bivalent typhoid vaccine Prokarium (Primary)
  • Indications Typhoid
  • Focus Adverse reactions
  • Sponsors Prokarium

    • Most Recent Events

    • 15 Oct 2019 New trial record
    • 08 Oct 2019 According to a Prokarium media release, the company has received an investment of 4.59 million pound from Wellcome to fund two clinical trials of its lead programme, Entervax (a bivalent vaccine against enteric fever).The funding from Wellcome will be used for this study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top